Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article Alzheimer’s disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis (2024) Erkert L, Gamez-Belmonte R, Kabisch M, Schödel L, Patankar J, Gonzalez Acera M, Mahapatro M, et al. Journal article Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet? (2024) Neurath M, Sands BE, Rieder F Journal article Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients. (2024) Lethen I, Lechner-Grimm K, Gabel M, Knauß A, Atreya R, Neurath M, Weigmann B Journal article Teachability of multispectral optoacoustic tomography (2024) Li Y, Gröhl J, Haney B, Caranovic M, Lorenz-Meyer E, Papatheodorou N, Kempf J, et al. Journal article Strategies for targeting cytokines in inflammatory bowel disease (2024) Neurath M Journal article, Review article The Proteomic Signature of Tissue Remodeling in Chronic Intestinal Inflammation (2024) Neurath M Journal article Biomarkers for Personalizing IBD Therapy: The Quest Continues (2024) Atreya R, Neurath M Journal article, Review article Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment (2024) Overbeek KA, Poulsen JL, Lanzillotta M, Vinge-Holmquist O, Macinga P, Demirci AF, Sindhunata DP, et al. Journal article